The eligibility criteria were age ≥18 years, CD4 count <200 cells/µL and not on other known hepatotoxic drugs concurrently (except co-trimoxazole, 960 mg per day, which was given for all participants before enrolment and during the follow up period according to the treatment guideline).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}